(1)
Lebwohl, M.; Blauvelt, A.; Menter, A.; Papp, K.; Jacobson, A. Long-Term Efficacy, Safety, and Patient-Reported Outcomes in a Phase 2 Study of Brodalumab. J of Skin 2019, 3, S26.